Vaccine trained immune cells were still in the brain after 20 years
Original title: Twenty-year persistence of WT1-specific cytotoxic T lymphocytes in peritumoral brain tissue by peptide vaccine therapy: Transcriptomic evidence for resident memory T-cell induction.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a close look at one patient, not a trial, and this vaccine is not approved.
The short version
In one patient, immune cells trained by a tumor vaccine were still sitting in the brain after 20 years of shots.
What was studied. Doctors studied one person with a slow growing brain tumor called a diffuse astrocytoma. This person had kept getting a WT1 peptide vaccine for 20 years. During a second brain surgery, doctors took a small piece of brain tissue from next to the tumor and tested the immune cells in it.
What they found. There were a lot of immune cells in that brain tissue. That stood out, because the brain usually keeps immune cells out. Of one kind of immune cell in the tissue, 38.4% were the kind the vaccine trains to spot the tumor marker. Most of those were memory cells that settle into tissue and stay there.
What this means, and what it doesn't
What it could mean: It suggests a vaccine like this can leave tumor fighting cells inside the brain for a very long time. The doctors think this local guard may have helped keep the tumor from coming back in this patient. Findings like this can help researchers design better cancer vaccines.
What it doesn't mean: This does not mean the vaccine is proven, and it is not a cure. This is one patient looked at closely, not a trial. There was no comparison group, so no one can say for sure that the vaccine is why the tumor stayed away. This vaccine is not standard care, and nothing here changes the treatment a person can get today.
Source: PubMed, July 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.